Is it legal to sell P medicines online?
Yes. Pharmacy medicines may be sold or supplied at a registered pharmacy by or under the supervision of a pharmacist under the Human Medicines Regulations 2012, and an online sale is lawful when it is genuinely a sale from that registered pharmacy: the transaction is attributed to the registered premises, a pharmacist supervises the sale, and the operation follows the General Pharmaceutical Council's (GPhC) February 2025 guidance for pharmacy services provided at a distance. The corollary defines the illegal market: general retailers, whether on their own websites or on marketplaces, may sell only general sale list (GSL) medicines, and anyone selling P medicines without a registered pharmacy behind the transaction is committing an offence, which is precisely the territory where the MHRA's enforcement operates.
The classification exists because P medicines are the middle tier deliberately: safe enough not to need a prescription, risky enough to need a pharmacist between the shelf and the patient.
"The operations that get in trouble are the ones that kept the shelf and lost the pharmacist."
Everything else in this guide is the online translation of that one idea.
The distance selling logo in 2026: what actually applies where
The single most repeated error in online pharmacy guidance is treating the distance selling logo as a current Great Britain requirement, and the accurate position is a clean split. In Great Britain, the EU common logo requirement ended on 1 January 2021: the MHRA's own medicine seller register states that from that date the logo applies only in Northern Ireland, the agency is not processing new GB applications and has said it is considering an alternative scheme. The GPhC's separate voluntary internet pharmacy logo also closed, on 31 December 2025. A GB pharmacy website's trust display is therefore its GPhC registration number, prominently shown and verifiable against the GPhC register, together with the ownership, premises and prescriber transparency the February 2025 guidance requires.
In Northern Ireland, the pre-2021 regime continues: anyone offering medicines online must register with the MHRA through the PCL portal, appear on the list of Northern Ireland registered online sellers and display the clickable distance selling logo on every page offering medicines, and, per the current GOV.UK guidance, a registered seller trading through a third-party marketplace must include the logo on each listing page offering medicines to the public. New applications can take up to 90 working days, so NI operations should treat registration as a launch dependency, not a formality. Selling online without required registration carries penalties of up to two years' imprisonment, a fine or both.
| Requirement | Great Britain | Northern Ireland |
|---|---|---|
| Distance selling logo | Not applicable since 1 January 2021 | Mandatory on every page and marketplace listing offering medicines |
| MHRA online seller registration | Not being processed for GB; alternative under consideration | Mandatory via the PCL portal, up to 90 working days |
| Registration number displayed and verifiable | GPhC registration required | PSNI registration applies to NI pharmacies |
| February 2025 distance services guidance | Applies | Applies to GB-registered operations; NI pharmacies follow PSNI equivalents |
Supervision: what it means online, and how the 2025 Order changes it
Today, every P medicine sale must be made by or under the supervision of a pharmacist, and online that translates into three capabilities the operation must actually have: a pharmacist with real oversight of P medicine orders before dispatch, the ability to intervene on an individual order, question, restrict or refuse, and evidence that the oversight and interventions happened. The inspection test is the one this series keeps quoting because inspectors keep using it: not "show me your policy" but "show me this specific order, and show me where the pharmacist intervened". An online P operation where orders flow from checkout to courier without a pharmacist's involvement being possible, let alone recorded, fails that test by design.
The law underneath is now changing in two dated stages under the Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025, approved in December 2025. Since 7 January 2026, a pharmacist may authorise any competent member of the team to hand out checked and bagged prescriptions, POM or P, already clinically checked and dispensed, in the pharmacist's absence. From 10 December 2026, the larger change arrives: pharmacists will be able to authorise a pharmacy technician to undertake or supervise the preparation, assembly, dispensing and sale and supply of medicines that today require a pharmacist, with the GPhC's supporting standards for superintendents and responsible pharmacists, and rules for responsible pharmacists, consulted on until 25 March 2026 and due before commencement. Two cautions for online operators: the changes are enabling, not mandatory, with both the authorising pharmacist and the authorised technician carrying accountability, and nothing has commenced yet that changes how a P medicine may be sold online today. The right move in 2026 is to build the supervision evidence the current law demands and revisit the operating model when the December standards land, not to anticipate them.
Can pharmacies sell P medicines on eBay?
Yes, lawfully and within a specific double gate, and the detail matters because eBay is simultaneously a legitimate channel for registered pharmacies and one of the MHRA's most active enforcement fronts. eBay UK's medicines policy permits pharmacy medicines to be offered only by pharmacists approved by eBay through its approval process, who must be registered with the GPhC and display the pharmacy logo related to their GPhC registration in the item description. The policy adds conditions with real operational bite: no personal health information may be communicated through eBay messaging under its member-to-member contact rules, so pharmacists must arrange telephone contact with buyers where a clinical conversation is necessary; products without a UK or Ireland marketing authorisation are prohibited; and GSL medicines may be sold only by business sellers meeting listing-content conditions. Around the policy sits enforcement at scale: eBay has cooperated with the MHRA for years, an AI algorithm developed with the platform identified and blocked more than two million violations of its prescription and non-prescription medicines policies in 2025 before listings went live, and the partnership's removals continue, including 215 unauthorised erectile dysfunction medicine listings announced in April 2026, that category being among the most illegally traded medicines in the UK.
Two facts complete the honest picture. First, the double gate is exactly that: eBay approval is a platform permission, not a regulatory clearance, and GPhC registration plus the distance services guidance apply to a marketplace sale exactly as to a sale on your own website, because the law follows the pharmacy, not the storefront. Second, the enforcement record includes registrants: a pharmacist was suspended for three months by the GPhC in a case, reported by Chemist and Druggist in February 2026, involving around £50,000 of pharmacy medicine sales made through eBay. The channel is lawful; treating it as a lower-scrutiny channel is how it becomes a fitness to practise citation.
Running a compliant eBay P medicine operation
The compliance challenge of a marketplace is structural: you are selling regulated medicines through a checkout you did not build, with messaging you may not use for clinical questions, on a platform whose policies change without your consent, and none of that dilutes your obligations by a single record. The workable model wraps your own clinical layer around eBay's transaction layer. Orders land from eBay into your pharmacy workflow before dispatch, where the pharmacist's oversight actually happens: review against quantity limits, cross-checking the buyer against order history for repeat and multiple purchasing, and a hold-and-contact route, by telephone, per eBay's rules, for anything that needs a conversation, with refusals executed as cancellations and recorded with reasons. Quantity caps are set per listing and enforced again at review, because a cap on one listing does not stop the same buyer ordering across several. And the records live in your own system, not the marketplace: the order, the pharmacist's review, any intervention and the outcome, attributed and timestamped, because when an inspector asks to see the order where the pharmacist intervened, "it's somewhere in eBay's seller dashboard" is not an answer.
Three further disciplines separate the durable eBay operations from the enforcement statistics. Treat listings as adverts, because legally they are: everything in the advertising section below applies to an eBay listing's title, images and description. Treat cross-channel visibility as a safety control: a buyer working your website and your eBay store in parallel defeats per-channel limits unless your duplicate detection sees both, which is an argument for one order-management system across every storefront. And treat platform dependency as a business risk: eBay's medicines policies and its MHRA-fed enforcement can change or end your channel abruptly, so a marketplace should extend a compliant operation you already run on your own site, never substitute for one. Northern Ireland sellers add the logo layer: the distance selling logo on each listing page offering medicines, per the MHRA's current marketplace guidance.
Advertising P medicines: allowed, with required content
Unlike POMs, P medicines may be advertised to the public, and the compliant advert is defined by what it must include and what it must not do. Under the advertising provisions of the Human Medicines Regulations 2012 as applied through the MHRA's Blue Guide and the CAP Code, an advert to the public must present the product accurately, include the name of the medicine and the common name of the active ingredient where it contains only one, carry the information necessary for correct use and include a clear invitation to read the label or leaflet. It must not be misleading, must not make treatment claims beyond the licence and must not encourage excessive or unnecessary use, which is the rule that catches multibuy promotions and urgency copy on misuse-prone lines. These requirements apply to every surface: product pages, category pages, emails, social posts and marketplace listings alike, and our SEO for online pharmacies guide covers the platform layer, including Google's certification-gated rules for promoting OTC medicines, in full.
The practical discipline is the same sign-off habit that article's compliance checklist establishes: every P medicine page and listing checked against the required-content list and the no-encouragement rule before it publishes, by someone accountable, with the check recorded.
Misuse-prone lines: where enforcement actually lands
Within the P category, a short list of lines carries most of the regulatory weight, and an online operation is judged on how it controls them: codeine and dihydrocodeine-containing analgesics, sedating antihistamines and sleep aids, and other products with established misuse patterns. The controls inspectors expect are concrete: meaningful quantity limits enforced at sale, detection of repeat and multiple ordering across time and channels, pharmacist referral triggers that actually route orders to a human, refusals recorded with reasons, and staff who can articulate why the limits exist. The GPhC's concern themes and the February 2025 guidance's expectations around medicines liable to misuse make this the part of a P operation most likely to be sampled, and the series' standing inspector question applies with full force here.
Codeine linctus was reclassified from P to prescription-only in 2024 after evidence of misuse and harm, much of it linked to easy multiple purchasing. When controls fail across a market, the regulator's remedy is not better controls but reclassification, which removes the line from every pharmacy's P shelf including the compliant ones. Every pharmacy running weak online limits on misuse-prone lines is, in a small way, voting to lose the category for everyone.
Records, the step-by-step sale and the inspection test
P medicine sales do not carry the POM register duty that private prescriptions do, but the distance services guidance's record-keeping expectations apply in full, and the operation should be able to reconstruct any sale: what was ordered, what checks ran, who reviewed it, what was supplied or refused and how it was dispatched. The table below is the whole system in one view, and it doubles as the quarterly self-audit: sample three P medicine orders, one of them a refused or held one, and walk the rows.
| Step | Control | Record |
|---|---|---|
| Listing or product page | Required advertising content; no excessive-use encouragement; sign-off | Dated marketing check |
| Point of sale | Structured suitability questions; quantity caps enforced | Order record with responses |
| Order review | Pharmacist oversight before dispatch; cross-channel duplicate check | Named review on the order |
| Intervention | Hold-and-contact route (telephone for eBay); restrict or refuse | Intervention or refusal log with reason |
| Supply | Correct product, in-date, with label and leaflet intact | Dispatch record |
| Delivery | Tracked despatch appropriate to the line | Tracking on the order |
Key takeaways
- P medicines may be sold online only as sales from a registered pharmacy by or under the supervision of a pharmacist, with the February 2025 distance guidance governing how; general retailers may sell GSL lines only.
- The distance selling logo has not applied in Great Britain since 1 January 2021 and now applies only to Northern Ireland sellers, who must register with the MHRA and show the logo on every page and marketplace listing offering medicines.
- The 2025 supervision Order commenced its first stage on 7 January 2026, with technician authorisation for sale and supply arriving 10 December 2026 subject to GPhC standards; nothing yet changes how P medicines are sold online today.
- eBay permits P medicine sales only by eBay-approved, GPhC-registered pharmacists, with the registration displayed in listings, no health information through eBay messaging and telephone contact for clinical conversations.
- eBay approval is a platform permission, not regulatory clearance: the full pharmacy law and guidance apply to marketplace sales, and a pharmacist has been suspended over roughly £50,000 of P medicine sales through eBay.
- P medicine adverts are lawful but must carry the required content, including the invitation to read the label, and must never encourage excessive use, which applies equally to marketplace listings.
- Misuse-prone lines need enforced quantity limits, cross-channel duplicate detection, pharmacist referral triggers and recorded refusals, and codeine linctus's 2024 reclassification shows what happens to a category when controls fail.
FAQs
Every storefront, one record.
Everything the inspection test demands of a P medicine operation, order review before dispatch, cross-channel duplicate detection, pharmacist attribution on every intervention and a reconstructable record per sale, is workflow, and Dataforge PMR runs it natively, whichever storefront the order came from. If you sell or plan to sell P medicines online, book a 30-minute demo and walk a flagged order through it.
Book a demo